Can confirm that Genentech is currently performing due dilligence on Sirtex with a view to licensing SIR-Spheres for use with Genetech's own Avastin for colon cancer in the liver.
genentech inc.
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $75.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| SRX (ASX) Chart |
Day chart unavailable